Anandamide by Gerald LitwackAnandamide by Gerald Litwack


byGerald LitwackEditorGerald Litwack

Hardcover | August 14, 2009

Pricing and Purchase Info

$302.29 online 
$336.94 list price
Earn 1,511 plum® points

Prices and offers may vary in store

Out of stock online

Not available in stores


First published in 1943,Vitamins and Hormonesis the longest-running serial published by Academic Press. The Editorial Board now reflects expertise in the field of hormone action, vitamin action, X-ray crystal structure, physiology, and enzyme mechanisms. Under the capable and qualified editorial leadership of Dr. Gerald Litwack,Vitamins and Hormonescontinues to publish cutting-edge reviews of interest to endocrinologists, biochemists, nutritionists, pharmacologists, cell biologists, and molecular biologists. Others interested in the structure and function of biologically active molecules like hormones and vitamins will, as always, turn to this series for comprehensive reviews by leading contributors to this and related disciplines. This volume reviews recent advances in the formation of endogenous cannabinoids and their receptors, metabolism and relation to disease processes.

*Longest running series published by Academic Press *Contributions by leading international authorities

Dr. Gerald Litwack obtained M.S. and PhD degrees from the University of Wisconsin Department of Biochemistry and remained there for a brief time as a Lecturer on Enzymes. Then he entered the Biochemical Institute of the Sorbonne as a Fellow of the National Foundation for Infantile Paralysis. He next moved to Rutgers University as an As...
Title:AnandamideFormat:HardcoverDimensions:536 pages, 9 × 6 × 0.98 inPublished:August 14, 2009Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123747821

ISBN - 13:9780123747822


Table of Contents

Table of Contents

Y. Okamoto, K. Tsuboi and N. Ueda,Enzymatic formation of anandamide

M.L. Yates and E.L. Barker,Organizedtrafficking of anandamide and related lipids

G.P. Mueller and W.J. Driscoll,Biosynthesis of oleamide

C.E. Goodfellow and M. Glass,Anandamide receptor signal transduction

A.J. Brown and C.R. Hiley,Is GPR55 an anandamide receptor?

E. Fride, N. Gobshtis, H. Dahan, A. Weller, A. Giuffrida and S. Ben-Shabat,The endocannabinoid system during development; emphasis on perinatal events and delayed effects

M. Bifulco, A. Santoro, C. Laezza and A.M. Malfitano,Cannabinoid receptor CB1 antagonists: state of the art and challenges

H.B. Bradshaw, N. Rimmerman, S.S.-J. Hu, S. Burstein and the late J.M. Walker,Novel endogenous N-acyl glycines: Identification and characterization

F.G. Correa, L. Mestre, F. Docagne, J. Borrell and C. Guaza,The endocannabinoid anandamide: from immunomodulation to neuroprotection, implications for multiple sclerosis

P. Grimaldi, G. Rossi, G. Catanzaro and M. Maccarrone,Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone

R. Malcher-Lopes and M. Buzzi,Glucocorticoid-regulated crosstalk between arachidonic acid and endocannabinoids biochemical pathways coordinates cognitive-, neuroimmune- and energy homeostasis-related adaptations to stress

L. Zhang and W. Xiong,Modulation of the Cys-loop ligand-gated ion channels by fatty acid and cannabinoids

D. McHugh and R.A. Ross,Endogenous cannabinoids and neutrophil chemotaxis

R. Pierantoni, G. Cobellis, R. Meccariello, G. Cacciola, R. Chianese, T. Chioccarelli and S. Fasano,CB1 activity in male reproduction: mammalian and non-mammalian animal models

A. Toth, P.M. Blumberg and J. Boczan,Anandamide and the vanilloid receptor (TRPV1)

L.B.M. Resstel, F.A. Moreira and F.S. Guimaraes,Endocannabinoid system and fear conditioning

N. Pasquariello, S. Oddi, M. Malaponti and M. Maccarrone,Regulation of gene transcription and keratinocyte differentiation by anandamide

G. Alpini and S. DeMorrow,Changes in the endocannabinoid system may give insight into new and effective treatments for cancer

R. Panday, V. Hegde, N. Singh, L. Hofseth, U. Singh, S. Ray, M. Nagarkatti and P. Nagarkatti,Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis